Hospital calls patients regarding meningitis scare
PETERBOROUGH — -- Monadnock Community Hospital has been contacting patients who have received injectable drug treatments using products from New England Compounding Pharmacy, the Massachusetts firm linked to the outbreak of fungal meningitis that has lead to 25 deaths nationwide.
“None of the NECC’s medications directly linked to the meningitis outbreak has ever been utilized here at MCH,” said Dr. Phil Vuocolo, the hospital’s chief medical officer, in a statement released Oct. 18.
The hospital did have a supply of other materials that came from NECC, and those were removed from use prior to the Food and Drug Administration’s Oct. 15 advisory urging hospitals to contact patients who had received treatment using NECC products.
Those products have been secured at the hospital, according to hospital spokesperson Phil McFarland. He did not know what future steps the FDA or other regulators might take regarding their disposal.
According to Vuocolo’s statement, patients who received any injectable drug from NECC that was produced after May 21 are being asked if they have experienced any unusual symptoms or reactions. The information will be used to assist the FDA in data collection.
McFarland said hospital officials had completed contacting patients last week.